# Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

> **NCT06435286** · PHASE2 · RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Suspected or Known Squamous Cell Neoplasia
- Prior History of Squamous Cell Dysplasia and /or Neoplasia

## Interventions

- **DRUG:** Proflavine Hemisulfate
- **DEVICE:** Artificial Intelligence Mobile High-Resolution Microendoscope

## Key facts

- **NCT ID:** NCT06435286
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06435286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06435286, "Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06435286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*